Know Labs Gestion

Gestion contrôle des critères 1/4

Le PDG Know Labs est Ron Erickson, nommé en Jan2023, a un mandat de 1.83 ans. La rémunération annuelle totale est $ 1.65M, composée du salaire de 27.4% et des bonus 72.6%, y compris les actions et options de la société. détient directement 1.38% des actions de la société, d'une valeur de $ 343.75K. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 1.8 ans et 5.4 ans.

Informations clés

Ron Erickson

Directeur général

US$1.7m

Rémunération totale

Pourcentage du salaire du PDG	27.4%
Durée du mandat du directeur général	1.8yrs
Propriété du PDG	1.4%
Durée moyenne d'occupation des postes de direction	1.8yrs
Durée moyenne du mandat des membres du conseil d'administration	5.4yrs

Mises à jour récentes de la gestion

Recent updates

Analyse de la rémunération des PDG

Comment la rémunération de Ron Erickson a-t-elle évolué par rapport aux bénéfices de Know Labs?
Date	Rémunération totale	Salaire	Bénéfices de l'entreprise
Sep 30 2024	US$2m	US$453k	-US$17m
Jun 30 2024	n/a	n/a	-US$16m
Mar 31 2024	n/a	n/a	-US$21m
Dec 31 2023	n/a	n/a	-US$20m
Sep 30 2023	US$1m	US$371k	-US$20m
Jun 30 2023	n/a	n/a	-US$23m
Mar 31 2023	n/a	n/a	-US$17m
Dec 31 2022	n/a	n/a	-US$19m
Sep 30 2022	US$2m	US$474k	-US$20m
Jun 30 2022	n/a	n/a	-US$22m
Mar 31 2022	n/a	n/a	-US$26m
Dec 31 2021	n/a	n/a	-US$25m
Sep 30 2021	US$2m	US$366k	-US$25m
Jun 30 2021	n/a	n/a	-US$22m
Mar 31 2021	n/a	n/a	-US$18m
Dec 31 2020	n/a	n/a	-US$16m
Sep 30 2020	US$827k	US$243k	-US$14m
Jun 30 2020	n/a	n/a	-US$12m
Mar 31 2020	n/a	n/a	-US$12m
Dec 31 2019	n/a	n/a	-US$10m
Sep 30 2019	US$291k	US$189k	-US$8m
Jun 30 2019	n/a	n/a	-US$5m
Mar 31 2019	n/a	n/a	-US$4m
Dec 31 2018	n/a	n/a	-US$3m
Sep 30 2018	US$201k	US$180k	-US$3m

Rémunération vs marché: La rémunération totale de Ron ($USD 1.65M ) est supérieure à la moyenne des entreprises de taille similaire sur le marché US ($USD 647.72K ).

Rémunération et revenus: La rémunération de Ron a augmenté alors que l'entreprise n'est pas rentable.

PDG

Ron Erickson (80 yo)

1.8yrs

Titularisation

US$1,652,327

Compensation

Mr. Ronald P. Erickson, J.D., also known as Ron, is the Founder of Know Labs, Inc. (formerly known as Visualant, Inc.) and has been its Chairman since February 2015 and Director since April 2003 and serves...

Équipe de direction

Nom	Position	Titularisation	Compensation	Propriété
Ronald Erickson	Founder	1.8yrs	US$1.65m	1.38% $ 343.7k
Peter Conley	CFO & Senior VP of Intellectual Property	2.5yrs	US$804.13k	0.0092% $ 2.3k
John Cronin	Interim CTO & Independent Director	less than a year	US$79.54k	0.015% $ 3.7k
James Anderson	Chief Medical Officer and Chairman of Medical	6.2yrs	pas de données	pas de données
Leonardo Trautwein	Chief Commercial Officer	1.8yrs	pas de données	0.018% $ 4.6k
Jordyn Hujar	Chief of Staff	no data	pas de données	pas de données
Dominic Klyve	Chief Science Officer	less than a year	pas de données	pas de données

1.8yrs

Durée moyenne de l'emploi

69yo

Âge moyen

Gestion expérimentée: L'équipe de direction de KNW n'est pas considérée comme expérimentée (ancienneté moyenne 1.8 ans), ce qui suggère une nouvelle équipe.

Membres du conseil d'administration

Nom	Position	Titularisation	Compensation	Propriété
Ronald Erickson	Founder	21.6yrs	US$1.65m	1.38% $ 343.7k
John Cronin	Interim CTO & Independent Director	less than a year	US$79.54k	0.015% $ 3.7k
James Anderson	Chief Medical Officer and Chairman of Medical	6.2yrs	pas de données	pas de données
William Owens	Independent Director	6.5yrs	US$198.07k	0.88% $ 218.9k
Carl Sundberg	Member of Scientific Advisory Board	1.7yrs	pas de données	pas de données
Larry Ellingson	Member of Medical	5.6yrs	US$60.40k	0.015% $ 3.7k
Jon Pepper	Independent Director	18.6yrs	US$198.07k	0.48% $ 118.7k
Ichiro Takesako	Independent Director	11.9yrs	US$198.07k	0.14% $ 35.8k
Donna Ryan	Member of Medical	5.2yrs	pas de données	pas de données
Benjamin Smarr	Member of Scientific Advisory Board	1.7yrs	pas de données	pas de données
Jessica Zendler	Member of Scientific Advisory Board	1.7yrs	pas de données	pas de données
Mark Aloia	Member of Scientific Advisory Board	1.7yrs	pas de données	pas de données

5.4yrs

Durée moyenne de l'emploi

73yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de KNW sont considérés comme expérimentés (ancienneté moyenne 5.4 ans).

Know Labs Gestion

Gestion contrôle des critères 1/4

Informations clés

Mises à jour récentes de la gestion

Know Labs, Inc Announces Executive Appointments

High number of new and inexperienced directors

Know Labs, Inc. Announces Board and Committee Changes

Know Labs, Inc., Annual General Meeting, Sep 26, 2024

Know Labs, Inc. Announces the Appointment of Chris Somogyi as President, International

Know Labs, Inc. Announces Board Appointments

Recent updates

Know Labs, Inc Announces Executive Appointments

Know Labs Receives Non Compliance Letter from NYSE American Regarding Sections 1003(a)(ii) and 1003(a)(iii)

High number of new and inexperienced directors

Know Labs, Inc. Announces Board and Committee Changes

Know Labs, Inc. has completed a Composite Units Offering in the amount of $3.445 million.

Know Labs, Inc., Annual General Meeting, Sep 26, 2024

Know Labs, Inc. Publishes Clinical Results in Leading Diabetes Journal

Know Labs, Inc. Announces Further Interim Results from a Clinical Research Study

Know Labs, Inc. Announces the Appointment of Chris Somogyi as President, International

Know Labs, Inc. to Present Clinical Research At the 2024 American Association of Clinical Endocrinology Annual Meeting

Know Labs, Inc. has filed a Follow-on Equity Offering in the amount of $5 million.

Know Labs, Inc. Announces Interim Results from its Most Recent Clinical Research Study

Know Labs, Inc. Announces Board Appointments

Know Labs, Inc. Expands Board of Directors

Know Labs, Inc. has completed a Follow-on Equity Offering in the amount of $7 million.

Know Labs, Inc., Annual General Meeting, Sep 22, 2023

Know Labs, Inc. Demonstrates Improved Accuracy of Machine Learning Model for Non-Invasive Glucose Monitor

Know Labs Completes Build of Portable Generation 1 Prototype for Non-Invasive Glucose Monitoring

Know Labs, Inc. Furthers External Validation of Bio-RFID(TM) Technology with Study Published in Sensors Journal

Know Labs, Inc. Study Validates Technical Feasibility of Its Novel Sensor for Non-Invasive Glucose Monitoring

Know Labs, Inc. Announces Changes to Executive Leadership Team

Know Labs, Inc. Announces Management Changes

Know Labs Common Stock Deleted from OTC Equity

Know Labs, Inc. has completed an IPO in the amount of $7.2 million.

Know Labs, Inc., Annual General Meeting, Sep 15, 2022

Know Labs, Inc. Announces Executive Appointments

Know Labs, Inc. Announces Executive Appointments

Know Labs Outlines Preparations for Pre-Submission Meeting with FDA

Know Labs, Inc. announced delayed 10-Q filing

Know Labs, Inc. Receives IRB Approval to Begin Internal Clinical Trial of Non-Invasive Glucose Monitoring Technology Bio-RFID™

Know Labs, Inc. Announces Introduction of New KnowU™ Diagnostic Device

Know Labs Receives New Patent for Its Non-Invasive Diagnostic Technology Platform, Bringing Patents Issued and Pending to Nearly 60

Know Labs Announces Successful Results from Pre-Clinical Study Validating Bio-RFID™ Platform Technology

Know Labs, Inc. announced that it has received $14.279 million in funding

Texas Biomedical Research Institute Issues Preliminary Results for Know Labs, Inc.'s Particle Bulb's Ability to Inactivate the SARS-CoV-2 Virus

Analyse de la rémunération des PDG

PDG

Titularisation

Compensation

Équipe de direction

Durée moyenne de l'emploi

Âge moyen

Membres du conseil d'administration

Durée moyenne de l'emploi

Âge moyen